Differential diagnosis of gout and tenosynovial giant cell tumor, a case report
https://doi.org/10.14412/1996-7012-2025-1-105-109
Abstract
Gout is the most common inflammatory joint disease, related to microcrystalline arthritis. With improper or inadequate treatment, gout can lead to disability.
A patient with a misdiagnosis of tophaceous gout is described in whom a differential diagnosis with a neoplasm was performed. As a result of the additional examination, a giant cell tenosynovial tumor of the second finger of the right hand was discovered.
About the Authors
P. I. Pyatnitskaya
Postgraduate Institute for Public Health Workers
Russian Federation
Russian Federation
Polina Igorevna Pyatnitskaya,
9, Krasnodarskaya Street, Khabarovsk 680009
E. N. Otteva
Postgraduate Institute for Public Health Workers
Russian Federation
Russian Federation
9, Krasnodarskaya Street, Khabarovsk 680009
E. V. Polukhina
Postgraduate Institute for Public Health Workers
Russian Federation
Russian Federation
9, Krasnodarskaya Street, Khabarovsk 680009
References
1. Nasonova VA, Barskova VG. Early diagnostics and treatment of gout – a scientifically substantiated requirement for improving the work and life prognosis of patients. NauchnoPrakticheskaya Revmatologia. 2004;(1):5-7. (In Russ.).
2. Sorotskaya VN, Eliseev MS. Gout with tophus mimicking a tumor of the thoracic spine. Nauchno-Prakticheskaya Revmatologia. 2018; 56(1):113-116. (In Russ.).
3. Mikuls TR, Saag KG. New insights into gout epidemiology. Curr Opin Rheumatol. 2006 Mar;18(2):199-203. doi: 10.1097/01.bor.0000209435.89720.7c.
4. Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2007 Feb 15;57(1):109-15. doi: 10.1002/art.22466.
5. Vladimirov SA, Eliseev MS, Radenska-Lopovok SG, Barskova VG. Differential diagnosis of rheumatoid arthritis and gout. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2008;2(4):39-41. (In Russ.). doi: 10.14412/1996-7012-2008-505.
6. Choi HK, Liu S, Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2005 Jan;52(1):283-9. doi: 10.1002/art.20761.
7. Li L, Yang C, Zhao Y, et al. Is hyperuricemia an independent risk factor for newonset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies. BMC Nephrol. 2014 Jul 27;15:122. doi: 10.1186/1471-2369-15-122.
8. Nasonov EL, editor. Gout. In: Rheumatology. Russian clinical guidelines. Moscow: GEOTAR-Media; 2017. Р. 253-64.
9. Dalbeth N, Stamp LK, Taylor WJ. What is remission in gout and how should we measure it? Rheumatology (Oxford). 2021 Mar 2;60(3): 1007-1009. doi: 10.1093/rheumatology/keaa853.
10. BashkovaIB, TarasovaLV, BusalaevaEI, et al. Clinical guidelines for the diagnosis and treatment of gout: how prepared are primary care physicians for their mandatory compliance? Terapiya. 2019;(8):74-80. (In Russ.).
11. Pascart T, Norberciak L, Ea HK, et al. Patients With Early-Onset Gout and Development of Earlier Severe Joint Involvement and Metabolic Comorbid Conditions: Results From a Cross-Sectional Epidemiologic Survey. Arthritis Care Res (Hoboken). 2019 Jul; 71(7):986-992. doi: 10.1002/acr.23706.
12. Chen-Xu M, Yokose C, Rai SK, et al. Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016. Arthritis Rheum. 2019 Jun;71(6):991-999. doi: 10.1002/art.40807.
13. Richette P, Doherty M, Pascual E, et al. 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis. 2020 Jan;79(1):31-38. doi: 10.1136/annrheumdis-2019-215315. Epub 2019 Jun 5.
14. Glazebrook KN, Guimarгes LS, Murthy NS, et al. Identification of intraarticular and periarticular uric acid crystals with dualenergy CT: initial evaluation. Radiology. 2011 Nov;261(2):516-24. doi: 10.1148/radiol.11102485.
15. Pastor CM, Perez EA, Casares EG. Usefulness of ultrasound in the diagnosis of crystal deposition diseases. Eur J Rheumatol. 2022 Mar 9;11(3):S334-S347. doi: 10.5152/eurjrheum.2022.20129. Online ahead of print.
16. Polukhina EV. Ultrasound examination of the musculoskeletal system in gout. Ul'trazvukovaya i funktsional'naya diagnostika. 2023; (2):62-79. (In Russ.).
17. Somerhausen NS, Fletcher CD. Diffusetype giant cell tumor: clinicopathologic and immunohistochemical analysis of 50 cases with extraarticular disease. Am J Surg Pathol. 2000 Apr;24(4):479-92. doi: 10.1097/00000478-200004000-00002.
18. Goni V, Gopinathan NR, Radotra BD, et al. Giant cell tumour of peroneus brevis tendon sheath-a case report and review of literature. BMJ Case Rep. 2012 Jul 13:2012: bcr0120125703. doi: 10.1136/bcr.01.2012.5703.
19. Glowacki K.A. Giant cell tumors of tendon sheath. Journal of the American Society for Surgery of the Hand. 2003:3(2):100-107. doi:10.1016/s1531-0914(03)00025-1.
20. https://ru.wikipedia.org/?curid= 4064250&oldid=127616130
21. Agarwal P, Gupta M, Srivastava A, Agarwal S. Cytomorphology of giant cell tumor of tendon sheath. A report of two cases. Acta Cytol. 1997 Mar-Apr;41(2):587-9. doi: 10.1159/000332562.
22. https://apicr.minzdrav.gov.ru/api.ashx?op=GetClinrecPdf&id= 251_1
23. De Schepper AM, Hogendoorn PC, Bloem JL. Giant cell tumors of the tendon sheath may present radiologically as intrinsic osseous lesions. Eur J Radiol. 2007 Feb;17(2): 499-502. doi: 10.1007/s00330-006-0320-4.
24. Palmerini E, Staals EL, Maki RG, et al. Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors. Eur J Cancer. 2015 Jan;51(2):210-7. doi: 10.1016/j.ejca.2014.11.001. Epub 2014 Nov 24.
25. Iyer VK, Kapila K, Verma K. Fine-needle aspiration cytology of giant cell tumor of tendon sheath. Diagn Cytopathol. 2003 Aug;29(2): 105-10. doi: 10.1002/dc.10319.
26. Wang Y, Tang J, Luo Y. The value of sonography in diagnosing giant cell tumors of the tendon sheath. J Ultrasound Med. 2007 Oct;26(10):1333-40. doi: 10.7863/jum.2007.26.10.1333.
27. Richette P, Doherty M, Pascual E, et al. 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis. 2020 Jan;79(1):31-38. doi: 10.1136/annrheumdis-2019-215315. Epub 2019 Jun 5.
28. Gutierrez M, Schmidt WA, Thiele RG, et al. OMERACT Ultrasound Gout Task Force group. International Consensus for ultrasound lesions in gout: results of Delphi process and web-reliability exercise. Rheumatology (Oxford). 2015 Oct;54(10):1797-805. doi: 10.1093/rheumatology/kev112. Epub 2015 May 13.
29. Ikeda K, Osamura N, Tomita K. Giant cell tumour in the tendon sheath of the hand: importance of the type of lesion. Scand J Plast Reconstr Surg Hand Surg. 2007;41(3):138-42. doi: 10.1080/02844310601159766.
30. Ozben H, Coskun T. Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases. BMC Musculoskelet Disord. 2019 Oct 21;20(1):457. doi: 10.1186/s12891-019-2866-8.
Review
For citations:
Pyatnitskaya PI, Otteva EN, Polukhina EV. Differential diagnosis of gout and tenosynovial giant cell tumor, a case report. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2025;19(1):105-109. https://doi.org/10.14412/1996-7012-2025-1-105-109
Views:
664
Email this article 